NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit

2009-1427

SANOFI-AVENTIS U.S. LLC, SANOFI-AVENTIS, and

DEBIOPHARM S.A.,

Plaintiffs-Appellants,

v.

SANDOZ, INC.,

Defendant-Appellee,

and

TEVA PARENTERAL MEDICINES, INC., TEVA PHARMACEUTICALS USA, INC., and

PHARMACHEMIE BV,

Defendants-Appellees,

and

MAYNE PHARMA LIMITED, MAYNE PHARMA (USA) INC., HOSPIRA AUSTRALIA

PTY LTD., and HOSPIRA, INC.,

Defend ants-Appellees,

and

BARR LABORATORIES, INC. and PLIVA-LACHEMA A.S.,

Defendants-Appellees,

and

W.C. HERAEUS GMBH,

Defendant-Appellee,

and

APP PHARMACEUTICALS, INC. and ABRAXIS BIOSCIENCE, INC.,
Defendants-Appellees,

and

ACTAVIS TOTOWA LLC, ACTAVIS, INC., and ACTAVIS GROUP HF,

Defendants-Appellees,

and

FRESENIUS KABI ONCOLOGY PLC (formerly known as Dabur Oncology plc) and

FRESENIUS KABI PHARMA LIMITED (formerly known as Dabur Pharma Limited),

Defendants-Appellees,

and

SUN PHARMACEUTICAL INDUSTRIES LTD. and CARACO PHARMACEUTICAL

LABORATORIES, LTD.,

Defendants-Appellees,

and

EBEWE PHARMA GES.M.B.H. NFG KG,

Defendants-Appellees,

and

MUSTAFA NEVZAT ILAC SANAYII A.S. (also known as MN Pharmaceuticals), PAR

PHARMACEUTICAL COMPANIES, INC., and PAR PHARMACEUTICAL, INC.,

Defendants-Appellees.

On appeal from the United States District Court for the District of New Jersey in case

no. 3:07-cv-2762, Judge Joel A. Pisano.

ON MOTION

Before MAYER, CLEVENGER, and RADER, Circuit Judges.

ORDER

2009-1427	 - 2 -
Sanofi-Aventis U.S. LLC et al. (Sanofi) move for a stay, pending appeal, of the

judgment of the United States District Court for the District of New Jersey entered on

June 30, 2009. Teva Parenteral Medicines, Inc. et al. (Teva), Mayne Pharma Limited et

al., Barr Laboratories, Inc. et al. (Barr), and W.C. Heraeus GmbH oppose. Sandoz, Inc.

and Mustafa Nevzat Sanayii A.S. et al. do not oppose. Sun Pharmaceutical Industries

Ltd. et al. take no position. Teva and Barr move for leave to file a reply to Sandoz's

response with reply attached. Sanofi moves for leave to reply with reply attached.

Upon consideration thereof,

IT IS ORDERED THAT:

The motion for a stay, pending appeal, of the judgment is granted.

Teva and Barr's motion for leave to file a reply is granted.

Sanofi's motion for leave to reply is granted.

The briefing schedule is expedited. Sanofi's opening brief is due no later

than July 31, 2009. The appellees' briefs are due no later than September 1, 2009.

Sanofi's reply brief and the joint appendix are due no later than September 11, 2009.

The case will be placed on the next available argument calendar, if practicable.

MAYER, Circuit Judge, would deny the stay, pending appeal.

FOR THE COURT

JUL 1 0 2009 /s/ Jan Horbalv

Date Jan Horbaly

Clerk

cc:	Robert B. Wilson, Esq.

Dominick A. Conde, Esq.

James H. Hurst, Esq.

David M. Hashmall, Esq.

2009-1427	 - 3 -

FILED

U.S. COURT OF APPEALS FOR

THE FEDERAL CIRCUIT

JUL 10 2009

JAN HORBALY

CLERK
Dutch Chung, Esq.

Patricia J. Thompson, Esq.

Charles D. Ossola, Esq.

Keith D. Parr, Esq.

Gail J. Standish, Esq.

Scott b. Feder, Esq.

Steven Lieberman, Esq.

Steven A. Maddox, Esq.

Andrew M. Berdon, Esq.

Daniel G. Brown, Esq.

Steven H. Sklar, Esq.

s19

2009-1427	 - 4 -